Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 19

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Inhibitory effect of minocycline on osteoclastogenesis in mouse bone marrow cells

Nagasawa, Tsuneyasu, Arai, Michitsugu, Togari, Akifumi·2011·Archives of Oral Biology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.archoralbio.2011.02.002

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 36

  1. Rifkin, 1994, Modulation of bone resorption by tetracyclines, Ann N Y Acad Sci, 732, 165, 10.1111/j.1749-6632.1994.tb24733.x · DOI
  2. Chopra, 2001, Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance, Microbiol Mol Biol Rev, 65, 232, 10.1128/MMBR.65.2.232-260.2001 · DOI · Paper page
  3. Seymour, 1995, Tetracyclines in the management of periodontal diseases. A review, J Clin Periodontol, 22, 22, 10.1111/j.1600-051X.1995.tb01767.x · DOI
  4. Golub, 1991, Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs, Crit Rev Oral Biol Med, 2, 297, 10.1177/10454411910020030201 · DOI · Paper page
  5. Golub, 1984, Tetracyclines inhibit tissue collagenase activity. A new mechanism in the treatment of periodontal disease, J Periodontal Res, 19, 651, 10.1111/j.1600-0765.1984.tb01334.x · DOI · Paper page
  6. Oringer, 2002, Effect of locally delivered minocycline microspheres on markers of bone resorption, J Periodontol, 73, 835, 10.1902/jop.2002.73.8.835 · DOI
  7. Goodson, 2007, Minocycline HCl microspheres reduce red-complex bacteria in periodontal disease therapy, J Periodontol, 78, 1568, 10.1902/jop.2007.060488 · DOI
  8. Cortelli, 2006, Longitudinal clinical evaluation of adjunct minocycline in the treatment of chronic periodontitis, J Periodontol, 77, 161, 10.1902/jop.2006.040409 · DOI
  9. Xu, 2006, A comparative study of systemic subantimicrobial and topical treatment of minocycline in experimental periodontitis of rats, Arch Oral Biol, 51, 794, 10.1016/j.archoralbio.2006.03.018 · doi:10.1016/j.archoralbio.2006.03.018
  10. Hellström, 2008, Local minocycline as an adjunct to surgical therapy in moderate to severe, chronic periodontitis, J Clin Periodontol, 35, 525, 10.1111/j.1600-051X.2008.01219.x · DOI
  11. Vernillo, 1998, Effects of tetracyclines on bone metabolism, Adv Dent Res, 12, 56, 10.1177/08959374980120012101 · DOI
  12. Gomes, 1984, Tetracyclines inhibit parathyroid hormone-induced bone resorption in organ culture, Experientia, 40, 1273, 10.1007/BF01946671 · DOI
  13. Rifkin, 1987, Effect of a chemically-modified tetracycline (CMT) on bone resorption in organ culture, J Cell Biol, 105, 216
  14. Bettany, 1998, Tetracycline derivatives induce apoptosis selectively in cultured monocytes and macrophages but not in mesenchymal cells, Adv Dent Res, 12, 136, 10.1177/08959374980120010901 · DOI · Paper page
  15. Bettany, 2000, Tetracyclines induce apoptosis in osteoclasts, Bone, 27, 75, 10.1016/S8756-3282(00)00297-0 · DOI · Paper page
  16. Williams, 1998, Effect of minocycline on osteoporosis, Adv Dent Res, 12, 71, 10.1177/08959374980120012401 · DOI
  17. Sasaki, 1998, Long-term therapy with a new chemically modified tetracycline (CMT-8) inhibits bone loss in femurs of ovariectomized rats, Adv Dent Res, 12, 76, 10.1177/08959374980120012501 · DOI
  18. Bain, 1997, Tetracycline prevents cancellous bone loss and maintains near-normal rates of bone formation in streptozotocin diabetic rats, Bone, 21, 147, 10.1016/S8756-3282(97)00104-X · DOI
  19. Ramamurthy, 2002, Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines, J Periodontol, 73, 726, 10.1902/jop.2002.73.7.726 · DOI
  20. Boyle, 2003, Osteoclast differentiation and activation, Nature, 423, 337, 10.1038/nature01658 · DOI · Paper page
  21. Takahashi, 1999, A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function, Biochem Biophys Res Commun, 256, 449, 10.1006/bbrc.1999.0252 · DOI · Paper page
  22. Asagiri, 2007, The molecular understanding of osteoclast differentiation, Bone, 40, 251, 10.1016/j.bone.2006.09.023 · DOI · Paper page
  23. Takayanagi, 2002, Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts, Dev Cell, 3, 889, 10.1016/S1534-5807(02)00369-6 · DOI · Paper page
  24. Koga, 2004, Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis, Nature, 428, 758, 10.1038/nature02444 · DOI · Paper page
  25. Negishi-Koga, 2009, Ca2+–NFATc1 signaling is an essential axis of osteoclast differentiation, Immunol Rev, 231, 241, 10.1111/j.1600-065X.2009.00821.x · DOI · Paper page
  26. Donahue, 1992, Regulation of cytoplasmic calcium concentration in tetracycline-treated osteoclasts, J Bone Miner Res, 7, 1313, 10.1002/jbmr.5650071111 · DOI
  27. Grenier, 2000, Iron-chelating activity of tetracyclines and its impact on the susceptibility of Actinobacillus actinomycetemcomitans to these antibiotics, Antimicrob Agents Chemother, 44, 763, 10.1128/AAC.44.3.763-766.2000 · DOI
  28. Takahashi, 1988, Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures, Endocrinology, 122, 1373, 10.1210/endo-122-4-1373 · DOI · Paper page
  29. Hartgers, 2000, DC-STAMP, a novel multimembrane-spanning molecule preferentially expressed by dendritic cells, Eur J Immunol, 30, 3585, 10.1002/1521-4141(200012)30:12<3585::AID-IMMU3585>3.0.CO;2-Y · DOI
  30. Kukita, 2004, RANKL-induced DC-STAMP is essential for osteoclastogenesis, J Exp Med, 200, 941, 10.1084/jem.20040518 · DOI · Paper page
  31. Minkin, 1982, Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function, Calcif Tissue Int, 34, 285, 10.1007/BF02411252 · DOI · Paper page
  32. Tezuka, 1992, Identification of osteopontin in isolated rabbit osteoclasts, Biochem Biophys Res Commun, 186, 911, 10.1016/0006-291X(92)90832-6 · DOI · Paper page
  33. Chomczynski, 1987, Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction, Anal Biochem, 162, 156, 10.1016/0003-2697(87)90021-2 · DOI · Paper page
  34. Wesierska-Gadek, 2005, A new multiplex assay allowing simultaneous detection of the inhibition of cell proliferation and induction of cell death, J Cell Biochem, 96, 1, 10.1002/jcb.20531 · DOI
  35. Suda, 1999, Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families, Endocr Rev, 20, 345, 10.1210/edrv.20.3.0367 · DOI · Paper page
  36. Sato, 1999, Microphthalmia-associated transcription factor interacts with PU.1 and c-Fos: determination of their subcellular localization, Biochem Biophys Res Commun, 254, 384, 10.1006/bbrc.1998.9918 · DOI

Cited by

See all 19

Metadata

Authors
Nagasawa, T., Arai, M., & Togari, A.
Venue
Archives of Oral Biology
Publisher
Elsevier BV
Published
2011-09
Volume
56
Issue
9
Pages
924-931
ISSN
0003-9969
Cited by
19
References
2
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibitory effect of minocycline on osteoclastogenesis in mouse bone marrow cells. https://app.cochat.ai/papers/10.1016/j.archoralbio.2011.02.002
The paper
Nagasawa, T., Arai, M., & Togari, A. (2011). Inhibitory effect of minocycline on osteoclastogenesis in mouse bone marrow cells. Archives of Oral Biology. https://doi.org/10.1016/j.archoralbio.2011.02.002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.